Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer’s Disease: A Rational Approach

Abstract excerpt

Amyloid is a prominent feature of Alzheimer's disease (AD). Yet, a linear linkage between amyloid-β peptide (Aβ) and the disease onset and progression has recently been questioned. In this context, the crucial partnership between Aβ and Nrf2 pathways is acquiring paramount importance, offering prospects for deciphering the Aβ-centered disease network. Here, we report on a new class of antiaggregating agents...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cholinesterase and Neurodegenerative Diseases
• Share to Free Radicals and Antioxidants
• Share to Genomics, phytochemicals, and oxidative stress